Cushing Syndrome

Hormonal disorder related to excess cortisol affecting multiple body systems

Cushing syndrome is a hormonal disorder caused by prolonged exposure to high cortisol levels. Learn about its definition, types, and medical scope.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Overview and Definition

The overview and definition of Cushing syndrome provides essential insight for patients and families navigating this complex endocrine disorder. This page is designed for international patients who are considering evaluation or treatment at Liv Hospital, offering clear explanations of the disease, its origins, clinical presentation, and the latest therapeutic options. Did you know that up to 10 % of patients with adrenal disorders are eventually diagnosed with Cushing syndrome? Understanding the condition early can dramatically improve outcomes and quality of life.

In the sections that follow, we will explore what Cushing syndrome is, why it occurs, how it is identified, and the range of treatments available—including specialized care coordinated for patients traveling from abroad. Whether you are a newly referred patient, a caregiver, or a health‑professional seeking a concise resource, this comprehensive guide aims to empower you with reliable, medically‑accurate information.

What Is Cushing Syndrome?

Cushing syndrome is a hormonal disorder caused by prolonged exposure to high levels of cortisol, the body’s primary stress hormone. The condition can arise from endogenous sources—such as adrenal tumors, pituitary adenomas (Cushing disease), or ectopic ACTH production—or from exogenous sources like long‑term glucocorticoid therapy.

Key physiological effects of excess cortisol include altered glucose metabolism, redistribution of body fat, and suppression of the immune system. The disease is relatively rare, affecting approximately 10–15 people per million annually, but its impact can be severe if left untreated.

Types of Cushing Syndrome

ACTH‑dependent – caused by pituitary or ectopic ACTH‑secreting tumors.
ACTH‑independent – resulting from adrenal hyperplasia or adrenal adenomas.
Iatrogenic – due to chronic administration of corticosteroid medications.

Diagnostic Criteria Overview

Test	Purpose	Typical Findings
24‑Hour Urinary Free Cortisol	Quantify cortisol excretion	Elevated levels >3× normal
Late‑Night Salivary Cortisol	Assess loss of diurnal rhythm	High midnight values
Dexamethasone Suppression Test	Evaluate feedback inhibition	Failure to suppress cortisol

The overview and definition of these subtypes helps clinicians tailor investigations and treatment plans to the underlying cause, which is crucial for optimal outcomes.

Causes and Risk Factors

Understanding the causes and risk factors for Cushing syndrome is essential for early detection and prevention. While many cases are linked to tumors, several other contributors merit attention.

Endogenous Causes

Pituitary adenomas (Cushing disease) – account for roughly 70 % of endogenous cases.
Adrenal adenomas or carcinomas – produce cortisol autonomously.
Ectopic ACTH secretion – often associated with small‑cell lung carcinoma or bronchial carcinoids.

Iatrogenic Factors

Long‑term use of glucocorticoids for conditions such as rheumatoid arthritis, asthma, or organ transplantation is the most common cause of exogenous Cushing syndrome. Even short bursts of high‑dose steroids can precipitate symptoms in susceptible individuals.

Genetic and Lifestyle Influences

Rare genetic mutations (e.g., in the PRKAR1A gene) can predispose individuals to adrenal hyperplasia. Additionally, chronic stress, obesity, and metabolic syndrome may exacerbate cortisol dysregulation, although they are not direct causes.

Clinicians at Liv Hospital conduct a thorough medical history, imaging studies, and hormonal assays to pinpoint the precise etiology, ensuring that each patient receives targeted therapy.

Signs, Symptoms, and Diagnosis

The clinical picture of Cushing syndrome is often subtle at first, leading to delayed diagnosis. Recognizing the hallmark signs and symptoms enables timely intervention.

Common Physical Manifestations

Central obesity with a “moon‑face” appearance.
Thin, fragile skin that bruises easily.
Purple striae (wide, reddish‑purple stretch marks) on the abdomen.
Proximal muscle weakness and fatigue.
Hypertension and glucose intolerance or overt diabetes.
Psychiatric changes: depression, anxiety, or cognitive impairment.

Diagnostic Workflow

Diagnosis begins with a detailed physical exam followed by biochemical confirmation. The following algorithm is routinely applied at Liv Hospital:

Screening with at least two of the three first‑line tests (urinary free cortisol, late‑night salivary cortisol, low‑dose dexamethasone suppression).
If biochemical evidence is positive, proceed to imaging: MRI of the pituitary, CT of the adrenal glands, or whole‑body PET/CT for ectopic sources.
High‑dose dexamethasone suppression or CRH stimulation tests differentiate pituitary from ectopic ACTH production.

Accurate diagnosis is the cornerstone of an effective overview and definition of treatment pathways, as therapeutic choices differ markedly between ACTH‑dependent and ACTH‑independent disease.

Treatment Options and Management

Therapeutic strategies for Cushing syndrome aim to normalize cortisol levels, alleviate symptoms, and prevent long‑term complications. Treatment selection depends on the underlying cause, patient comorbidities, and, for international patients, logistical considerations.

Surgical Interventions

Pituitary surgery (transsphenoidal adenomectomy) – first‑line for Cushing disease, offering cure rates of 70‑90 %.
Adrenalectomy – indicated for adrenal adenomas or carcinomas; can be performed laparoscopically or robotically.
Removal of ectopic ACTH tumors – requires precise localization; may involve thoracic or abdominal surgery.

Medical Therapy

When surgery is contraindicated or incomplete, medications such as ketoconazole, metyrapone, or osilodrostat can inhibit cortisol synthesis. Pasireotide and cabergoline target ACTH secretion in pituitary disease.

Radiation and Emerging Treatments

For residual pituitary disease, stereotactic radiosurgery offers a non‑invasive option. Ongoing clinical trials explore novel agents like glucocorticoid receptor antagonists (e.g., relacorilant) and immunotherapy for ectopic sources.

Post‑Treatment Monitoring

After curative surgery, patients undergo regular hormonal assessments to detect recurrence. Lifelong follow‑up includes bone density scans, cardiovascular risk evaluation, and metabolic monitoring.

Prognosis and Follow‑Up Care

With timely and appropriate management, the prognosis for Cushing syndrome has markedly improved. Survival rates are high for patients with benign adenomas, while adrenal carcinoma carries a more guarded outlook.

Long‑Term Health Considerations

Persistent hypertension or diabetes may require ongoing pharmacologic control.
Osteoporosis risk remains elevated; calcium, vitamin D, and bisphosphonates are often prescribed.
Psychological support is essential, as mood disorders can persist even after biochemical remission.

International Patient Follow‑Up

Liv Hospital’s 360‑degree international patient program ensures seamless continuity of care. After discharge, patients receive a detailed summary, tele‑consultation options, and coordination with local physicians to maintain monitoring schedules.

Why Choose Liv Hospital

Liv Hospital is a JCI‑accredited, Istanbul‑based center renowned for its multidisciplinary expertise in endocrine disorders, including Cushing syndrome. International patients benefit from dedicated coordinators who handle appointments, airport transfers, interpreter services, and comfortable accommodation. Advanced diagnostic imaging, robotic surgery, and a team of board‑certified endocrinologists ensure that each patient receives world‑class, personalized care from start to finish.

Ready to take the next step toward recovery? Contact Liv Hospital today to schedule a comprehensive evaluation and let our expert team guide you through every stage of your Cushing syndrome treatment journey.

Book a Free Certified Online
Doctor Consultation

Related Doctors

Liv Hospital Ulus Assoc. Prof. MD. Seda Turgut Endocrinology and Metabolism

Liv Hospital Ulus Prof. MD. Demet Yetkin Endocrinology and Metabolism

Liv Hospital Vadistanbul Prof. MD. Berçem Ayçiçek Endocrinology and Metabolism

Liv Hospital Vadistanbul Prof. MD. Gönül Çatlı Pediatric Endocrinology

Liv Hospital Vadistanbul Prof. MD. Kubilay Ükinç Endocrinology and Metabolism

Liv Hospital Bahçeşehir Assoc. Prof. MD. Sevil Arı Yuca Pediatric Endocrinology and Metabolic Diseases

Liv Hospital Bahçeşehir Assoc. Prof. MD. Ufuk Özuğuz Endocrinology and Metabolism

Liv Hospital Bahçeşehir Spec. MD. Hüseyin Çelik Endocrinology and Metabolism

Liv Hospital Topkapı Prof. MD. Mehmet Aşık Endocrinology and Metabolism

Liv Hospital Topkapı Prof. MD. Nujen Çolak Bozkurt Endocrinology and Metabolism

Liv Hospital Ankara Prof. MD. Banu Aktaş Yılmaz Endocrinology and Metabolism

Liv Hospital Ankara Prof. MD. Peyami Cinaz Pediatric Endocrinology

Liv Hospital Ankara Prof. MD. Serdar Güler Endocrinology and Metabolism

Liv Hospital Ankara Spec. MD. Elif Sevil Alagüney Endocrinology and Metabolism

Liv Hospital Gaziantep Prof. MD. Zeynel Beyhan Endocrinology and Metabolic Diseases

Liv Hospital Gaziantep Spec. MD. Tahsin Özenmiş Endocrinology and Metabolism

Liv Hospital Samsun Assoc. Prof. MD. Gülçin Cengiz Ecemiş Endocrinology and Metabolism

Liv Hospital Samsun Spec. MD. Esra Tutal Endocrinology and Metabolic Diseases

Liv Bona Dea Hospital Bakü MD. FİDAN QULU Endocrinology and Metabolism

Spec. MD. Zümrüt Kocabey Sütçü Pediatric Endocrinology

Liv Hospital Ulus + Liv Hospital Vadistanbul + Liv Hospital Topkapı Prof. MD. Cengiz Kara Pediatric Endocrinology

30 Years of Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Reviews from 9,651

4,9

Worth a look

Was this article helpful?

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

FREQUENTLY ASKED QUESTIONS

What is Cushing syndrome and what causes it?

Cushing syndrome results from chronic excess of cortisol, the body’s main stress hormone. Endogenous causes include ACTH‑dependent tumors such as pituitary adenomas (Cushing disease) or ectopic ACTH‑secreting cancers, and ACTH‑independent adrenal adenomas or hyperplasia. Exogenous, or iatrogenic, Cushing is most often due to long‑term glucocorticoid medication for conditions like asthma or rheumatoid arthritis. Rare genetic mutations can also predispose individuals. The source of excess cortisol determines the specific subtype and guides treatment.

How is Cushing syndrome diagnosed?

Initial screening uses at least two of three first‑line tests: 24‑hour urinary free cortisol, late‑night salivary cortisol, and low‑dose dexamethasone suppression. Positive biochemical results are followed by imaging—MRI of the pituitary, CT of the adrenals, or PET/CT for ectopic sources. High‑dose dexamethasone suppression or CRH stimulation helps differentiate pituitary from ectopic ACTH production. A definitive diagnosis requires both hormonal confirmation and anatomical localization.

What are the common symptoms of Cushing syndrome?

Patients often present with a characteristic pattern of fat redistribution: a rounded “moon‑face,” a fat pad between the shoulders (buffalo hump), and central obesity. The skin becomes fragile, bruises easily, and develops wide purple striae on the abdomen. Muscular weakness, especially proximally, fatigue, high blood pressure, and impaired glucose metabolism leading to diabetes are frequent. Neuropsychiatric changes such as depression, anxiety, and cognitive deficits may also occur, making early recognition essential.

What treatment options are available for Cushing syndrome?

For ACTH‑dependent disease, transsphenoidal pituitary surgery is first‑line, offering 70‑90 % cure rates. Adrenal adenomas are treated with laparoscopic or robotic adrenalectomy. Ectopic ACTH tumors require precise surgical removal. When surgery is not feasible or incomplete, medical agents such as ketoconazole, metyrapone, osilodrostat, pasireotide, or cabergoline suppress cortisol production or ACTH secretion. Stereotactic radiosurgery can address residual pituitary tissue, and emerging therapies like glucocorticoid‑receptor antagonists are under investigation. Post‑treatment monitoring is essential to detect recurrence.

How does Liv Hospital support international patients with Cushing syndrome?

The hospital’s international patient program assigns a dedicated coordinator to arrange airport transfers, interpreter services, and comfortable lodging. Patients receive a detailed medical summary, tele‑consultation options, and assistance in sharing records with local physicians. Multidisciplinary teams—including endocrinologists, surgeons, radiologists, and psychologists—ensure comprehensive evaluation and personalized treatment plans. Ongoing monitoring, including hormonal assays and imaging, is organized remotely to maintain continuity after discharge.

What is the prognosis after treatment for Cushing syndrome?

When the underlying tumor is benign and completely resected, most patients achieve biochemical remission and experience significant improvement in quality of life. Survival rates are high for pituitary and adrenal adenomas. In contrast, adrenal carcinoma carries a poorer outlook due to aggressive behavior and higher recurrence risk. Persistent hypertension, diabetes, or osteoporosis may require lifelong management. Psychological support remains important, as mood disorders can linger even after cortisol normalization.